along with the challenges of access to health technologies to address the burden of communicable disease low and middleincome countries are also increasingly grappling with the rising burdens of noncommunicable diseases yet newer patented treatments often carry price tags that are not affordable for the vast majority of patients in low and middleincome countries taking a closer look at the growing interest in niche markets and personalized medicine world medical and health policy vol